tirzepatide ndc Lilly releases Zepbound® (tirzepatide) single-dose vials, expanding supply and access for adults living with obesity Zepbound 10 mg/0.5 mL injection

Gastrointestinal side effects The most commonly reported side effects of tirzepatide, regardless of delivery method, involve the gastrointestinal system

Zepbound is FDA-approved for adults: To reduce body weight and maintain long-term weight management in those who have excess weight and a weight-related health condition (e.g

Patients receiving MOUNJARO in combination with an insulin secretagogue (e.g., sulfonylurea) or insulin may have an increased risk of hypoglycemia, including severe hypoglycemia [see Adverse Reactions (6.1), Drug Interactions (7.1)]

We serve patients from Apple Valley CA, Victorville CA, Adelanto CA, Hesperia CA, Crestline CA, Highland CA, and Barstow CA

GLP-1 also slows down how fast food moves through your stomach (gastric emptying), making you feel full longer, and helps control appetite by lowering blood sugar levels and promoting weight loss

Tirzepatide reduces body weight by increasing fat utilization via the central nervous system-adipose tissue axis in male mice